Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Catheter ablation for atrial flutter: a survey by the European Heart Rhythm Association and Canadian Heart Rhythm Society.

Glover BM, Chen J, Hong KL, Boveda S, Baranchuk A, Haugaa KH, Dorian P, Potpara TS, Crystal E, Mitchell B, Tilz R, Leong-Sit P, Dagres N.

Europace. 2016 Dec;18(12):1880-1885. doi: 10.1093/europace/euw402.

PMID:
28130373
2.

Catheter ablation for atrial flutter: a survey by the European Heart Rhythm Association and Canadian Heart Rhythm Society.

Glover BM, Chen J, Hong KL, Boveda S, Baranchuk A, Haugaa KH, Dorian P, Potpara TS, Crystal E, Mitchell B, Tilz R, Leong-Sit P, Dagres N.

Europace. 2017 Jan 5. pii: euw392. doi: 10.1093/europace/euw392. [Epub ahead of print]

PMID:
28057775
3.

Cost Effectiveness of Implantable Cardiac Monitor-Guided Intermittent Anticoagulation for Atrial Fibrillation: An Analysis of the REACT.COM Pilot Study.

Steinhaus DA, Zimetbaum PJ, Passman RS, Leong-Sit P, Reynolds MR.

J Cardiovasc Electrophysiol. 2016 Aug 30. doi: 10.1111/jce.13090. [Epub ahead of print]

PMID:
27571718
4.

Sustained Ventricular Tachycardia in Apparently Normal Hearts: Medical Therapy Should be the First Step in Management.

Saeid AK, Klein GJ, Leong-Sit P.

Card Electrophysiol Clin. 2016 Sep;8(3):631-9. doi: 10.1016/j.ccep.2016.04.012. Review.

PMID:
27521096
5.

Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation?

Leong-Sit P, Healey JS.

Can J Cardiol. 2016 Oct;32(10):1203.e9-1203.e11. doi: 10.1016/j.cjca.2016.03.011. No abstract available.

PMID:
27345609
6.

Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy.

Herman AR, Gardner M, Steinberg C, Yeung-Lai-Wah JA, Healey JS, Leong-Sit P, Krahn AD, Chakrabarti S.

Heart Rhythm. 2016 Oct;13(10):1964-70. doi: 10.1016/j.hrthm.2016.06.021.

PMID:
27321245
7.

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.

Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS.

N Engl J Med. 2016 Jul 14;375(2):111-21. doi: 10.1056/NEJMoa1513614.

8.

A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation.

Orr N, Arnaout R, Gula LJ, Spears DA, Leong-Sit P, Li Q, Tarhuni W, Reischauer S, Chauhan VS, Borkovich M, Uppal S, Adler A, Coughlin SR, Stainier DY, Gollob MH.

Nat Commun. 2016 Apr 12;7:11303. doi: 10.1038/ncomms11303.

9.

Aerobic Fitness and Risk of Ventricular Arrhythmia Following Physical Exertion.

Chahal HS, Mostofsky E, Mittleman MA, Suskin N, Speechley M, Skanes AC, Leong-Sit P, Manlucu J, Yee R, Klein GJ, Gula LJ.

Can J Cardiol. 2016 Apr;32(4):533-8. doi: 10.1016/j.cjca.2015.12.026.

PMID:
27017150
10.

Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study.

Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B, Ayala-Paredes F, Tang AS, Sapp J, Sturmer M, Keren A, Wells GA, Birnie DH; BRUISE CONTROL Investigators..

J Am Coll Cardiol. 2016 Mar 22;67(11):1300-8. doi: 10.1016/j.jacc.2016.01.009.

PMID:
26988951
11.

Atrial fibrillation management: evaluating rate vs rhythm control.

Nguyen T, Jolly U, Sidhu K, Yee R, Leong-Sit P.

Expert Rev Cardiovasc Ther. 2016 Jun;14(6):713-24. doi: 10.1586/14779072.2016.1164033. Review.

PMID:
26960034
12.

Atrial flutter and atrial fibrillation ablation - sequential or combined? A cost-benefit and risk analysis of primary prevention pulmonary vein ablation.

Gula LJ, Skanes AC, Klein GJ, Jenkyn KB, Redfearn DP, Manlucu J, Roberts JD, Yee R, Tang AS, Leong-Sit P.

Heart Rhythm. 2016 Jul;13(7):1441-8. doi: 10.1016/j.hrthm.2016.02.018.

PMID:
26944890
13.

A New, Simplified Measure of Anticoagulation Control With Warfarin: Potential Role in the Direct Oral Anticoagulant Era.

Leong-Sit P, Healey JS.

Can J Cardiol. 2016 Oct;32(10):1203.e5-1203.e7. doi: 10.1016/j.cjca.2015.11.018. No abstract available.

PMID:
26922290
14.

Pulmonary Vein Isolation With Incomplete Antral Ablation Lines: Is More Ablation Necessary? Results of a Randomized Trial.

Gula LJ, Leong-Sit P, Manlucu J, Hillock L, Yee R, Tang AS, Klein GJ, Skanes AC.

J Cardiovasc Electrophysiol. 2016 Mar;27(3):298-302. doi: 10.1111/jce.12876.

PMID:
26538372
15.

Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study.

Passman R, Leong-Sit P, Andrei AC, Huskin A, Tomson TT, Bernstein R, Ellis E, Waks JW, Zimetbaum P.

J Cardiovasc Electrophysiol. 2016 Mar;27(3):264-70. doi: 10.1111/jce.12864.

16.

A detailed description and assessment of outcomes of patients with hospital recorded QTc prolongation.

Laksman Z, Momciu B, Seong YW, Burrows P, Conacher S, Manlucu J, Leong-Sit P, Gula LJ, Skanes AC, Yee R, Klein GJ, Krahn AD.

Am J Cardiol. 2015 Apr 1;115(7):907-11. doi: 10.1016/j.amjcard.2015.01.016.

PMID:
25665761
17.

Atrial fibrillation and heart failure: a bad combination.

Leong-Sit P, Tang AS.

Curr Opin Cardiol. 2015 Jan 8. [Epub ahead of print]

PMID:
25574895
18.

Reduced Uptake of Family Screening in Genotype-Negative Versus Genotype-Positive Long QT Syndrome.

Hanninen M, Klein GJ, Laksman Z, Conacher SS, Skanes AC, Yee R, Gula LJ, Leong-Sit P, Manlucu J, Krahn AD.

J Genet Couns. 2015 Aug;24(4):558-64. doi: 10.1007/s10897-014-9776-6.

PMID:
25273952
19.

Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.

Laksman Z, Yee R, Stirrat J, Gula LJ, Skanes AC, Leong-Sit P, Manlucu J, McCarty D, Turkistani Y, Scholl D, Rajchl M, Goela A, Islam A, Thompson RT, Drangova M, White JA.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1040-7. doi: 10.1161/CIRCEP.114.001729.

20.

Primary prevention PVI for atrial fibrillation--weighing the risks and benefits.

Gula LJ, Leong-Sit P, Skanes AC.

Heart Rhythm. 2014 Sep;11(9):1573-4. doi: 10.1016/j.hrthm.2014.05.033. No abstract available.

PMID:
24882507

Supplemental Content

Loading ...
Support Center